765 related articles for article (PubMed ID: 1875966)
21. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
22. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
[TBL] [Abstract][Full Text] [Related]
23. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
Salerno F; Badalamenti S; Lorenzano E; Moser P; Incerti P
Hepatology; 1991 Apr; 13(4):707-13. PubMed ID: 1826281
[TBL] [Abstract][Full Text] [Related]
25. Peritoneovenous shunts--devices of last resort.
Shepherd KE; Miller BJ
Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
[TBL] [Abstract][Full Text] [Related]
26. [Surgical treatment of refractory ascites with peritoneovenous shunt].
Massari R; Fulgente R; Marinelli S; Romessis M
Chir Ital; 1995; 47(1):57-0. PubMed ID: 8706187
[TBL] [Abstract][Full Text] [Related]
27. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
28. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
[TBL] [Abstract][Full Text] [Related]
29. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
[TBL] [Abstract][Full Text] [Related]
30. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
31. Early implantation of Denver shunt.
Oida T; Mimatsu K; Kawasaki A; Kano H; Kuboi Y; Fukino N; Kida K; Matsuoka S; Amano S
Hepatogastroenterology; 2011; 58(112):2026-8. PubMed ID: 22234072
[TBL] [Abstract][Full Text] [Related]
32. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
Zervos EE; McCormick J; Goode SE; Rosemurgy AS
Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of ascites in liver cirrhosis].
Gramkow M; Christensen E
Ugeskr Laeger; 1994 Sep; 156(37):5256-65. PubMed ID: 7941060
[TBL] [Abstract][Full Text] [Related]
34. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS
South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519
[TBL] [Abstract][Full Text] [Related]
35. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
Zhao J; Yuan C; Wang D; Li X
Chin Med J (Engl); 2000 Jan; 113(1):27-30. PubMed ID: 11775204
[TBL] [Abstract][Full Text] [Related]
36. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
Ginés P; Arroyo V; Quintero E; Planas R; Bory F; Cabrera J; Rimola A; Viver J; Camps J; Jiménez W
Gastroenterology; 1987 Aug; 93(2):234-41. PubMed ID: 3297907
[TBL] [Abstract][Full Text] [Related]
37. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
38. Albumin infusion fails to restore circulatory function following paracentesis of tense ascites as assessed by beat-to-beat haemodynamic measurements.
Schneditz D; Bachler I; Stadlbauer V; Stauber RE
Int J Clin Pract; 2008 Dec; 62(12):1851-7. PubMed ID: 17927765
[TBL] [Abstract][Full Text] [Related]
39. Peritoneovenous shunts for malignant ascites.
Sonnenfeld T; Tydén G
Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
